Hepatitis B Clinical Trials in Beijing, Beijing Municipality
6 recruitingBeijing, Beijing Municipality, China
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
Chronic Hepatitis B Virus (HBV) Infection
Brii Biosciences Limited250 enrolled14 locationsNCT06650852
Recruiting
Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
Chronic Hepatitis B
Beijing Friendship Hospital2,000 enrolled1 locationNCT06779864
Recruiting
Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon
Chronic Hepatitis B
Minghui Li120 enrolled1 locationNCT06696664
Recruiting
Phase 1
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
Hepatocellular CarcinomaHCCHepatitis B Virus Related Hepatocellular Carcinoma
SCG Cell Therapy Pte. Ltd.38 enrolled7 locationsNCT06617000
Recruiting
Not Applicable
Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients
Chronic Hepatitis B
Beijing 302 Hospital50 enrolled1 locationNCT06457477
Recruiting
Real-world Study Optimizing Nucleotide-analogues
Hepatitis B, Chronic
Huashan Hospital20,000 enrolled44 locationsNCT05937178